Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-01-23

Clinical Trial Update: Diclofenac Gel in the Treatment of Cervicogenic Headache [Phase 3]

View source ↗

Summary

The Phase 3 clinical trial evaluating diclofenac gel for cervicogenic headache has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac Gel (diclofenac)

Snippet

Sponsor: Loma Linda University | Conditions: Cervicogenic Headache | Phase 3 | Status: WITHDRAWN